You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
15 September 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Tuesday that it has agreed to acquire a potential best-in-class trispecific T cell-engager (TCE) from privately held biotechnology company Chimagen Biosciences.Th...
15 September 2026 - PSMA Connect, a Healthcare Group Purchasing Organisation (GPO), and HealthIQ Solutions, a provider of remote patient care management and clinical technology, said on Monday that they have formed a new strategic provider alliance.T...
14 September 2026 - Chinese biopharmaceutical company Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG: 6990) on Monday announced that it has published phase III results for its HER2-targeted antibody–drug conjugate trastuzumab botidotin ...
14 September 2026 - Biotechnology company Armata Pharmaceuticals Inc (NYSE American: ARMP) reported on Monday that it has received U.S. Food and Drug Administration Breakthrough Therapy designation for AP-SA02, its intravenous multi-phage product can...
14 September 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) disclosed on Monday that its Phase III SERENA-4 trial of Etcamah (camizestrant) in combination with palbociclib did not achieve its primary endpoint of a sta...
14 September 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) on Monday reported positive registrational Phase I/II ARROS-1 data for Jideytro (zidesamtinib) in previously untreated ROS1-positive non-small cell lung cancer (NSCLC), supp...
14 September 2026 - Meant Health, a digital health platform that connects patients with licensed clinicians for evaluation, prescription and ongoing care coaching, announced on Saturday that it is expanding telehealth access to FDA-approved GLP-1 med...